Perrigo approval
This article was originally published in The Tan Sheet
Executive Summary
Generics firm receives ANDA approval Sept. 23 for 100 mg/5 mL ibuprofen oral suspension, equivalent to McNeil's Children's Motrin. Perrigo and Alpharma recently settled FTC antitrust charges over a 1998 marketing agreement under which Perrigo marketed a Children's Motrin equivalent during Alpharma's exclusivity period (1"The Tan Sheet" Aug. 16, 2004, p. 3)...
You may also be interested in...
Rx Or OTC Statins May Be Springboard For Perrigo Generics Unit
Perrigo is looking into developing its own line of private label statin drugs
FTC Settlement May Portend Antitrust Scrutiny Of ANDA First-Filer Deals
The Federal Trade Commission's settlement with Perrigo and Alpharma suggests that deals struck between competing first-to-file generic drug manufacturers may trigger future antitrust scrutiny
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.